Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Sales | 0 | 0 | 3,254 | 2,530 | 4,138 |
| Gross Profit | 0 | 0 | 3,270 | 2,530 | 4,130 |
| Operating Expenses | 10,250 | 8,500 | 11,740 | 8,710 | 10,040 |
| Operating Income | -10,250 | -8,500 | -8,486 | -6,180 | -5,902 |
| Interest Expense | 130 | 130 | 150 | 80 | 100 |
| Other Income | 470 | 570 | 676 | 660 | 792 |
| Pre-tax Income | -9,910 | -8,060 | -7,960 | -5,600 | -5,210 |
| Net Income Continuous | -9,919 | -8,510 | -7,938 | -5,605 | -5,216 |
| Net Income | $-9,919 | $-8,510 | $-7,938 | $-5,605 | $-5,216 |
| EPS Basic Total Ops | -7,678.46 | -6,238.75 | -6,118.78 | -4,319.14 | -4,079.18 |
| EPS Basic Continuous Ops | -7,630.00 | -6,546.15 | -6,106.15 | -4,311.54 | -4,012.31 |
| EPS Diluted Total Ops | -7,678.46 | -6,238.75 | -6,118.78 | -4,319.14 | -4,079.18 |
| EPS Diluted Continuous Ops | -7,630.00 | -6,546.15 | -6,106.15 | -4,311.54 | -4,012.31 |
| EBITDA(a) | $-9,920 | $-7,890 | $-7,906 | $-5,470 | $-5,542 |